Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Bo Yin, Bin Peng, Ying Luo, Shanghua Fan, Ting Xiao, Xiaoli Zou & Hongjuan Dong. (2021) Efficacy of Repetitive Transcranial Magnetic Stimulation Combined with Botulinum Toxin Type A for Benign Essential Blepharospasm Patients Accompanied by Anxiety and Depression. Neuropsychiatric Disease and Treatment 17, pages 2707-2711.
Read now
Read now
Articles from other publishers (21)
Eric Finzi. (2023) Botulinum Toxin Treatment for Depression: A New Paradigm for Psychiatry. Toxins 15:5, pages 336.
Crossref
Crossref
Heqing Zheng, Lanxiang Wu, Sheng Tian, Mingxu Liu, Qingqing Zhan, Xinping Yu, Yonggang Xie, Xianhui Zhong & Wei Wu. (2023) Effect of botulinum toxin type A on non-motor symptoms and quality of life in Meige syndrome. Frontiers in Neurology 14.
Crossref
Crossref
Ana Carolina de Figueiredo Costa, Everton Cavalcante da Silva & Delane Viana Gondim. (2022) Botulinum Toxin in Facial Aesthetics Affects the Emotion Process: A Meta-analysis of Randomized Controlled Trials. Clinical Psychopharmacology and Neuroscience 20:4, pages 600-608.
Crossref
Crossref
Anastasia D. Dubinskaya, Olga V. Yurova & Anatoliy D. Fesyun. (2022) Myofascial Facial Massage in Correction of Stress, Anxiety and Depressive Symptoms: a Сase Report. Bulletin of Rehabilitation Medicine 21:5, pages 129-139.
Crossref
Crossref
Han Zhao, Wushuang Wang, Tong Lin & Lan Gong. (2022) Serum Metabolomics of Benign Essential Blepharospasm Using Liquid Chromatography and Orbitrap Mass Spectrometry. Oxidative Medicine and Cellular Longevity 2022, pages 1-16.
Crossref
Crossref
Marc Axel Wollmer, Michelle Magid, Tillmann H. C. Kruger & Eric Finzi. (2022) Treatment of Depression with Botulinum Toxin. Toxins 14:6, pages 383.
Crossref
Crossref
Anastasia D. Dubinskaya, Olga V. Yurova, Anatoliy D. Fesyun & Anastasia A. Kukshina. (2022) Correction of Psycho-Emotional Status Using Neuromuscular Relaxation of the Face. Journal of Nervous & Mental Disease 210:3, pages 179-185.
Crossref
Crossref
Chengyun Wang, Xiangyu Zhu, Lei Xia, Peng Xie, Xiangyang Tian, Jin Shang & Qiu Han. (2021) Botulinum toxin A improves psychological distress in patients with hemifacial spasm. Acta Neurologica Belgica 122:1, pages 43-49.
Crossref
Crossref
Kimberly M. Winges & Barbara Yates. 2022. Albert and Jakobiec's Principles and Practice of Ophthalmology. Albert and Jakobiec's Principles and Practice of Ophthalmology
5721
5736
.
M. Axel Wollmer, Tigran Makunts, Tillmann H. C. Krüger & Ruben Abagyan. (2021) Postmarketing safety surveillance data reveals protective effects of botulinum toxin injections against incident anxiety. Scientific Reports 11:1.
Crossref
Crossref
Matteo Costanzo, Daniele Belvisi, Isabella Berardelli, Annalisa Maraone, Viola Baione, Gina Ferrazzano, Carolina Cutrona, Giorgio Leodori, Massimo Pasquini, Antonella Conte, Giovanni Fabbrini, Giovanni Defazio & Alfredo Berardelli. (2021) Effect of Botulinum Toxin on Non-Motor Symptoms in Cervical Dystonia. Toxins 13:9, pages 647.
Crossref
Crossref
Ajisha Yesudhas, Risna Kanjirassery Radhakrishnan, Aishwarya Sukesh, Sowbarnika Ravichandran, Nivethitha Manickam & Mahesh Kandasamy. (2021) BOTOX® counteracts the innate anxiety-related behaviours in correlation with increased activities of key antioxidant enzymes in the hippocampus of ageing experimental mice. Biochemical and Biophysical Research Communications 569, pages 54-60.
Crossref
Crossref
Daisy A. Burr, Rachel G. Pizzie & David J. M. Kraemer. (2021) Anxiety, not regulation tendency, predicts how individuals regulate in the laboratory: An exploratory comparison of self-report and psychophysiology. PLOS ONE 16:3, pages e0247246.
Crossref
Crossref
Bhupesh Vaidya, Kritika Dhamija, Priyanka Guru & Shyam Sunder Sharma. (2021) Parkinson's disease in women: Mechanisms underlying sex differences. European Journal of Pharmacology 895, pages 173862.
Crossref
Crossref
Azalea Tenerife Pajo, Adrian Isidoro Espiritu & Roland Dominic Go Jamora. (2021) Impact and Challenges of the COVID-19 Pandemic on Patients Requiring Botulinum Toxin A Treatment. Journal of Movement Disorders 14:1, pages 29-33.
Crossref
Crossref
Tigran Makunts, Marc Axel Wollmer & Ruben Abagyan. (2020) Postmarketing safety surveillance data reveals antidepressant effects of botulinum toxin across various indications and injection sites. Scientific Reports 10:1.
Crossref
Crossref
Hongjuan Dong, Ying Luo, Shanghua Fan, Bo Yin, Chao Weng & Bin Peng. (2020) Screening Gene Mutations in Chinese Patients With Benign Essential Blepharospasm. Frontiers in Neurology 10.
Crossref
Crossref
Somdattaa Ray, PramodK Pal & Ravi Yadav. (2020) Nonmotor symptoms and sleep disturbances in patients with blepharospasm. Annals of Movement Disorders 3:3, pages 156.
Crossref
Crossref
Kimberly M. Winges & Barbara Yates. 2020. Albert and Jakobiec's Principles and Practice of Ophthalmology. Albert and Jakobiec's Principles and Practice of Ophthalmology
1
16
.
Rasetti-Escargueil & Popoff. (2019) Antibodies and Vaccines Against Botulinum Toxins: Available Measures and Novel Approaches. Toxins 11:9, pages 528.
Crossref
Crossref
A. D. Dubinskaya, A. A. Kukshina, O. V. Yurova, A. V. Kotel'nikova & E. N. Gulaev. (2019) Modern views on the relationship between psychoemotional state and the bioelectrical activity of facial muscles. Voprosy kurortologii, fizioterapii i lechebnoi fizicheskoi kul'tury 96:6, pages 61.
Crossref
Crossref